Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2013

Open Access 01-12-2013 | Research article

Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study

Authors: Helena Forsblad-d’Elia, Hanna Wallberg, Eva Klingberg, Hans Carlsten, Lennart Bergfeldt

Published in: BMC Musculoskeletal Disorders | Issue 1/2013

Login to get access

Abstract

Background

Cardiac conduction disturbances are common in spondyloarthropathies such as ankylosing spondylitis (AS). Whether their occurrence can be linked to signs and symptoms of rheumatic disease activity is an unsettled issue addressed in this study.

Methods

In this cross-sectional study patients with AS according to modified New York criteria but without psoriasis, inflammatory bowel disease, dementia, pregnancy, other severe diseases such as malignancy and difficulties in answering questionnaires were invited; and 210 participated (120 men), mean age 49 years (SD 13; range: 16–77). Questionnaires, physical examination, ECG, and laboratory tests were performed at the same visit.

Results

Cardiac conduction disturbances were common and diagnosed in 10-33%, depending on if conservative or less conservative predefined criteria were applied. They consisted mostly of 1st degree atrio-ventricular block and prolonged QRS duration, but one patient had a pacemaker and 7 more had complete bundle branch blocks. Conduction abnormalities were associated mainly with age, male gender and body weight, and not with laboratory measures of inflammation or with Bath Ankylosing Spondylitis Disease Activity Index. Neither were they associated with the presence of HLA B27, which was found in 87% of all patients; the subtype B270502 dominated in all patients.

Conclusions

Cardiac conduction abnormalities are common in AS, but not associated with markers of disease activity or specific B27 subtypes. Even relatively mild conduction system abnormalities might, however, indirectly affect morbidity and mortality.
Appendix
Available only for authorised users
Literature
1.
go back to reference McCarey D, Sturrock RD: Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol. 2009, 27 (4 Suppl 55): S124-S126.PubMed McCarey D, Sturrock RD: Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol. 2009, 27 (4 Suppl 55): S124-S126.PubMed
2.
go back to reference Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J: Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol. 2011, 27 (2): 174-182.CrossRefPubMed Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J: Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol. 2011, 27 (2): 174-182.CrossRefPubMed
3.
go back to reference Mathieu S, Motreff P, Soubrier M: Spondyloarthropathies: an independent cardiovascular risk factor?. Joint Bone Spine. 2010, 77 (6): 542-545.CrossRefPubMed Mathieu S, Motreff P, Soubrier M: Spondyloarthropathies: an independent cardiovascular risk factor?. Joint Bone Spine. 2010, 77 (6): 542-545.CrossRefPubMed
4.
go back to reference Prati C, Claudepierre P, Pham T, Wendling D: Mortality in spondylarthritis. Joint Bone Spine. 2011, 78 (5): 466-470.CrossRefPubMed Prati C, Claudepierre P, Pham T, Wendling D: Mortality in spondylarthritis. Joint Bone Spine. 2011, 78 (5): 466-470.CrossRefPubMed
5.
go back to reference Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT: Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum. 2004, 34 (3): 585-592.CrossRefPubMed Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT: Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum. 2004, 34 (3): 585-592.CrossRefPubMed
6.
go back to reference Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV: Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006, 33 (11): 2167-2172.PubMed Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV: Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006, 33 (11): 2167-2172.PubMed
7.
go back to reference Kang JH, Chen YH, Lin HC: Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis. 2010, 69 (6): 1165-1168.CrossRefPubMed Kang JH, Chen YH, Lin HC: Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis. 2010, 69 (6): 1165-1168.CrossRefPubMed
8.
go back to reference Rodrigues CE, Vieira WP, Bortoluzzo AB, Goncalves CR, Da Silva JA, Ximenes AC, Bertolo MB, Ribeiro SL, Keiserman M, Menin R: Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis. Rev Bras Reumatol. 2012, 52 (3): 375-383.CrossRefPubMed Rodrigues CE, Vieira WP, Bortoluzzo AB, Goncalves CR, Da Silva JA, Ximenes AC, Bertolo MB, Ribeiro SL, Keiserman M, Menin R: Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis. Rev Bras Reumatol. 2012, 52 (3): 375-383.CrossRefPubMed
9.
10.
go back to reference Engfeldt B, Romanus R, Yden S: Histological studies of pelvo-spondylitis ossificans (ankylosing spondylitis) correlated with clinical and radiological findings. Ann Rheum Dis. 1954, 13 (3): 219-228.CrossRefPubMedPubMedCentral Engfeldt B, Romanus R, Yden S: Histological studies of pelvo-spondylitis ossificans (ankylosing spondylitis) correlated with clinical and radiological findings. Ann Rheum Dis. 1954, 13 (3): 219-228.CrossRefPubMedPubMedCentral
11.
go back to reference Brewerton DA, Gibson DG, Goddard DH, Jones TJ, Moore RB, Pease CT, Revell PA, Shapiro LM, Swettenhams KV: The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet. 1987, 1 (8540): 995-998.CrossRefPubMed Brewerton DA, Gibson DG, Goddard DH, Jones TJ, Moore RB, Pease CT, Revell PA, Shapiro LM, Swettenhams KV: The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet. 1987, 1 (8540): 995-998.CrossRefPubMed
12.
go back to reference van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27 (4): 361-368.CrossRefPubMed van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27 (4): 361-368.CrossRefPubMed
13.
go back to reference Dik VK, Peters MJ, Dijkmans PA, Van der Weijden MA, De Vries MK, Dijkmans BA, Van der Horst-Bruinsma IE, Nurmohamed MT: The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol. 2010, 39 (1): 38-41.CrossRefPubMed Dik VK, Peters MJ, Dijkmans PA, Van der Weijden MA, De Vries MK, Dijkmans BA, Van der Horst-Bruinsma IE, Nurmohamed MT: The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol. 2010, 39 (1): 38-41.CrossRefPubMed
14.
go back to reference Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E, Hedberg M, Carlsten H, Forsblad-d’Elia H: Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012, 14 (3): R108-CrossRefPubMedPubMedCentral Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E, Hedberg M, Carlsten H, Forsblad-d’Elia H: Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012, 14 (3): R108-CrossRefPubMedPubMedCentral
15.
go back to reference Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewe R, Maksymowych W: The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009, 68 (Suppl 2): ii1-ii44.CrossRefPubMed Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewe R, Maksymowych W: The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009, 68 (Suppl 2): ii1-ii44.CrossRefPubMed
16.
go back to reference Sahi SP, Winfield CR: Third-degree heart block developing in an HLA-B27-positive individual with a family history of ankylosing spondylitis. Br J Clin Pract. 1990, 44 (12): 794-795.PubMed Sahi SP, Winfield CR: Third-degree heart block developing in an HLA-B27-positive individual with a family history of ankylosing spondylitis. Br J Clin Pract. 1990, 44 (12): 794-795.PubMed
17.
go back to reference Sheehan NJ: HLA-B27: what’s new?. Rheumatology (Oxford). 2010, 49 (4): 621-631.CrossRef Sheehan NJ: HLA-B27: what’s new?. Rheumatology (Oxford). 2010, 49 (4): 621-631.CrossRef
18.
go back to reference Bergfeldt L, Edhag O, Vallin H: Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis. A 25-year follow-up study of 68 patients. Acta Med Scand. 1982, 212 (4): 217-223.CrossRefPubMed Bergfeldt L, Edhag O, Vallin H: Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis. A 25-year follow-up study of 68 patients. Acta Med Scand. 1982, 212 (4): 217-223.CrossRefPubMed
19.
go back to reference Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ: Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. Jama. 2009, 301 (24): 2571-2577.CrossRefPubMedPubMedCentral Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ: Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. Jama. 2009, 301 (24): 2571-2577.CrossRefPubMedPubMedCentral
20.
go back to reference Holmqvist F, Daubert JP: First-degree AV block-an entirely benign finding or a potentially curable cause of cardiac disease?. Ann Noninvasive Electrocardiol. 2013, 18 (3): 215-224.CrossRefPubMed Holmqvist F, Daubert JP: First-degree AV block-an entirely benign finding or a potentially curable cause of cardiac disease?. Ann Noninvasive Electrocardiol. 2013, 18 (3): 215-224.CrossRefPubMed
21.
go back to reference Ishikawa T, Kimura K, Miyazaki N, Tochikubo O, Usui T, Kashiwagi M, Ishii M: Diastolic mitral regurgitation in patients with first-degree atrioventricular block. Pacing Clin Electrophysiol. 1992, 15 (11 Pt 2): 1927-1931.CrossRefPubMed Ishikawa T, Kimura K, Miyazaki N, Tochikubo O, Usui T, Kashiwagi M, Ishii M: Diastolic mitral regurgitation in patients with first-degree atrioventricular block. Pacing Clin Electrophysiol. 1992, 15 (11 Pt 2): 1927-1931.CrossRefPubMed
22.
go back to reference Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010, 31 (19): 2369-2429.CrossRefPubMed Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010, 31 (19): 2369-2429.CrossRefPubMed
23.
go back to reference Cleland JG, Buga L, Ghosh J, Nasir M: Applying evidence-based device care in cardiovascular patients: which patient with heart failure and what device?. J R Coll Physicians Edinb. 2010, 40 (3): 229-239.CrossRefPubMed Cleland JG, Buga L, Ghosh J, Nasir M: Applying evidence-based device care in cardiovascular patients: which patient with heart failure and what device?. J R Coll Physicians Edinb. 2010, 40 (3): 229-239.CrossRefPubMed
Metadata
Title
Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study
Authors
Helena Forsblad-d’Elia
Hanna Wallberg
Eva Klingberg
Hans Carlsten
Lennart Bergfeldt
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2013
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-14-237

Other articles of this Issue 1/2013

BMC Musculoskeletal Disorders 1/2013 Go to the issue